CIPLA
Back to Income Statement
|
CIPLA Last 5 Year Operating Profit History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Operating Profit (Excl OI) | ₹6,291 Cr | ₹4,990 Cr | ₹4,512 Cr | ₹4,249 Cr | ₹3,181 Cr |
What is the latest Operating Profit of CIPLA ?
Year | Operating Profit |
---|---|
Mar2025 | ₹6,291 Cr |
Mar2024 | ₹4,990 Cr |
Mar2023 | ₹4,512 Cr |
Mar2022 | ₹4,249 Cr |
Mar2021 | ₹3,181 Cr |
How is Operating Profit of CIPLA Trending?
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹6,291 Cr | 26.07 | |
Mar2024 | ₹4,990 Cr | 10.60 | |
Mar2023 | ₹4,512 Cr | 6.20 | |
Mar2022 | ₹4,249 Cr | 33.57 | |
Mar2021 | ₹3,181 Cr | - |
Compare Operating Profit of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹121,085.2 Cr | -2.8% | -5% | -7.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹380,666.0 Cr | -3.5% | 0% | -12.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹151,060.0 Cr | -6.6% | -7.2% | 9.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,605.0 Cr | -2.5% | -0.4% | 1.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,556.0 Cr | -3.8% | -0.6% | -4.2% | Stock Analytics | |
MANKIND PHARMA | ₹102,422.0 Cr | -4.4% | 0.3% | -7.7% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | -2.8% |
-5% |
-7.8% |
SENSEX | -2.7% |
-0.5% |
-5.3% |
You may also like the below Video Courses